Reported revenue of $1.8 million for the first quarter of 2026, a 24% increase compared to $1.5 million in the same period of 2025. Net income for the quarter was $26.5 million, compared to a net loss of $128.2 million in Q1 2025, largely driven by non-cash gains from the change in fair value of common stock warrants. Operating expenses increased to $39.7 million from $20.1 million in the prior year period, reflecting higher R&D and G&A costs associated with scaling operations and public company requirements. As of March 31, 2026, the company held $90.2 million in cash, cash equivalents, and marketable securities. Subsequent to the quarter, on May 8, 2026, the company closed a private placement of common stock and warrants for $100 million in gross proceeds.